Glimepiride

Chemical formula: C₂₄H₃₄N₄O₅S  Molecular mass: 490.62 g/mol  PubChem compound: 3476

Therapeutic indications

Glimepiride is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

Glimepiride is indicated for the treatment of type 2 diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Glimepiride is contraindicated in the following cases:

Insulin dependent diabetes

at least one of
Insulin dependent diabetes mellitus type IA
Insulin dependent diabetes mellitus type IB

Diabetic coma

Diabetic coma with ketoacidosis

Ketoacidosis

Ketoacidosis

Severe renal function disorders

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic function disorders

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2019: AMARYL Tablet
Summary of Product Characteristics (SPC) 2014: GLIMEPIRIDE Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈